{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T07:58:49Z","timestamp":1790323129589,"version":"4.1.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2017,2,13]],"date-time":"2017-02-13T00:00:00Z","timestamp":1486944000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2017,2,13]],"date-time":"2017-02-13T00:00:00Z","timestamp":1486944000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Immunol"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1038\/ni.3684","type":"journal-article","created":{"date-parts":[[2017,2,13]],"date-time":"2017-02-13T18:25:12Z","timestamp":1487010312000},"page":"464-473","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":182,"title":["Defining the antibody cross-reactome directed against the influenza virus surface glycoproteins"],"prefix":"10.1038","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5568-5420","authenticated-orcid":false,"given":"Raffael","family":"Nachbagauer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariana","family":"Hirsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Margine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayaka","family":"Iida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldo","family":"Barrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcela","family":"Ferres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4008-503X","authenticated-orcid":false,"given":"Randy A","family":"Albrecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adolfo","family":"Garc\u00eda-Sastre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole M","family":"Bouvier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimihito","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael A","family":"Medina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Palese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Krammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,2,13]]},"reference":[{"key":"BFni3684_CR1","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1186\/s12879-014-0670-5","volume":"14","author":"K Jayasundara","year":"2014","unstructured":"Jayasundara, K., Soobiah, C., Thommes, E., Tricco, A.C. & Chit, A. Natural attack rate of influenza in unvaccinated children and adults: a meta-regression analysis. BMC Infect. Dis. 14, 670 (2014).","journal-title":"BMC Infect. Dis."},{"key":"BFni3684_CR2","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/nrd4529","volume":"14","author":"F Krammer","year":"2015","unstructured":"Krammer, F. & Palese, P. Advances in the development of influenza virus vaccines. Nat. Rev. Drug Discov. 14, 167\u2013182 (2015).","journal-title":"Nat. Rev. Drug Discov."},{"key":"BFni3684_CR3","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/nrmicro1208","volume":"3","author":"T Horimoto","year":"2005","unstructured":"Horimoto, T. & Kawaoka, Y. Influenza: lessons from past pandemics, warnings from current incidents. Nat. Rev. Microbiol. 3, 591\u2013600 (2005).","journal-title":"Nat. Rev. Microbiol."},{"key":"BFni3684_CR4","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1084\/jem.20101352","volume":"208","author":"J Wrammert","year":"2011","unstructured":"Wrammert, J. et al. Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection. J. Exp. Med. 208, 181\u2013193 (2011).","journal-title":"J. Exp. Med."},{"key":"BFni3684_CR5","doi-asserted-by":"publisher","first-page":"2573","DOI":"10.1073\/pnas.1200039109","volume":"109","author":"N Pica","year":"2012","unstructured":"Pica, N. et al. Hemagglutinin stalk antibodies elicited by the 2009 pandemic influenza virus as a mechanism for the extinction of seasonal H1N1 viruses. Proc. Natl. Acad. Sci. USA 109, 2573\u20132578 (2012).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFni3684_CR6","doi-asserted-by":"publisher","first-page":"4728","DOI":"10.1128\/JVI.03509-12","volume":"87","author":"I Margine","year":"2013","unstructured":"Margine, I. et al. H3N2 influenza virus infection induces broadly reactive hemagglutinin stalk antibodies in humans and mice. J. Virol. 87, 4728\u20134737 (2013).","journal-title":"J. Virol."},{"key":"BFni3684_CR7","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1038\/nature07231","volume":"455","author":"X Yu","year":"2008","unstructured":"Yu, X. et al. Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors. Nature 455, 532\u2013536 (2008).","journal-title":"Nature"},{"key":"BFni3684_CR8","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1093\/infdis\/jir661","volume":"204","author":"SE Ohmit","year":"2011","unstructured":"Ohmit, S.E., Petrie, J.G., Cross, R.T., Johnson, E. & Monto, A.S. Influenza hemagglutination-inhibition antibody titer as a correlate of vaccine-induced protection. J. Infect. Dis. 204, 1879\u20131885 (2011).","journal-title":"J. Infect. Dis."},{"key":"BFni3684_CR9","doi-asserted-by":"publisher","first-page":"20248","DOI":"10.1073\/pnas.1320524110","volume":"110","author":"NS Heaton","year":"2013","unstructured":"Heaton, N.S., Sachs, D., Chen, C.J., Hai, R. & Palese, P. Genome-wide mutagenesis of influenza virus reveals unique plasticity of the hemagglutinin and NS1 proteins. Proc. Natl. Acad. Sci. USA 110, 20248\u201320253 (2013).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFni3684_CR10","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/279246a0","volume":"279","author":"JW Yewdell","year":"1979","unstructured":"Yewdell, J.W., Webster, R.G. & Gerhard, W.U. Antigenic variation in three distinct determinants of an influenza type A haemagglutinin molecule. Nature 279, 246\u2013248 (1979).","journal-title":"Nature"},{"key":"BFni3684_CR11","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.3390\/v6062465","volume":"6","author":"TJ Wohlbold","year":"2014","unstructured":"Wohlbold, T.J. & Krammer, F. In the shadow of hemagglutinin: a growing interest in influenza viral neuraminidase and its role as a vaccine antigen. Viruses 6, 2465\u20132494 (2014).","journal-title":"Viruses"},{"key":"BFni3684_CR12","doi-asserted-by":"publisher","first-page":"e110026","DOI":"10.1371\/journal.pone.0110026","volume":"9","author":"X Yang","year":"2014","unstructured":"Yang, X. et al. A beneficiary role for neuraminidase in influenza virus penetration through the respiratory mucus. PLoS One 9, e110026 (2014).","journal-title":"PLoS One"},{"key":"BFni3684_CR13","doi-asserted-by":"publisher","first-page":"e02556","DOI":"10.1128\/mBio.02556-14","volume":"6","author":"TJ Wohlbold","year":"2015","unstructured":"Wohlbold, T.J. et al. Vaccination with adjuvanted recombinant neuraminidase induces broad heterologous, but not heterosubtypic, cross-protection against influenza virus infection in mice. MBio 6, e02556 (2015).","journal-title":"MBio"},{"key":"BFni3684_CR14","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.virol.2012.06.003","volume":"432","author":"JD Easterbrook","year":"2012","unstructured":"Easterbrook, J.D. et al. Protection against a lethal H5N1 influenza challenge by intranasal immunization with virus-like particles containing 2009 pandemic H1N1 neuraminidase in mice. Virology 432, 39\u201344 (2012).","journal-title":"Virology"},{"key":"BFni3684_CR15","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1126\/science.1171491","volume":"324","author":"DC Ekiert","year":"2009","unstructured":"Ekiert, D.C. et al. Antibody recognition of a highly conserved influenza virus epitope. Science 324, 246\u2013251 (2009).","journal-title":"Science"},{"key":"BFni3684_CR16","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1126\/science.1204839","volume":"333","author":"DC Ekiert","year":"2011","unstructured":"Ekiert, D.C. et al. A highly conserved neutralizing epitope on group 2 influenza A viruses. Science 333, 843\u2013850 (2011).","journal-title":"Science"},{"key":"BFni3684_CR17","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/nsmb.1566","volume":"16","author":"J Sui","year":"2009","unstructured":"Sui, J. et al. Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses. Nat. Struct. Mol. Biol. 16, 265\u2013273 (2009).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"BFni3684_CR18","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1126\/science.1222908","volume":"337","author":"C Dreyfus","year":"2012","unstructured":"Dreyfus, C. et al. Highly conserved protective epitopes on influenza B viruses. Science 337, 1343\u20131348 (2012).","journal-title":"Science"},{"key":"BFni3684_CR19","doi-asserted-by":"publisher","first-page":"5512","DOI":"10.1128\/JVI.03030-12","volume":"87","author":"S Jegaskanda","year":"2013","unstructured":"Jegaskanda, S., Weinfurter, J.T., Friedrich, T.C. & Kent, S.J. Antibody-dependent cellular cytotoxicity is associated with control of pandemic H1N1 influenza virus infection of macaques. J. Virol. 87, 5512\u20135522 (2013).","journal-title":"J. Virol."},{"key":"BFni3684_CR20","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.4049\/jimmunol.1201574","volume":"190","author":"S Jegaskanda","year":"2013","unstructured":"Jegaskanda, S. et al. Cross-reactive influenza-specific antibody-dependent cellular cytotoxicity antibodies in the absence of neutralizing antibodies. J. Immunol. 190, 1837\u20131848 (2013).","journal-title":"J. Immunol."},{"key":"BFni3684_CR21","doi-asserted-by":"publisher","first-page":"e1003207","DOI":"10.1371\/journal.ppat.1003207","volume":"9","author":"BJ Laidlaw","year":"2013","unstructured":"Laidlaw, B.J. et al. Cooperativity between CD8+ T cells, non-neutralizing antibodies, and alveolar macrophages is important for heterosubtypic influenza virus immunity. PLoS Pathog. 9, e1003207 (2013).","journal-title":"PLoS Pathog."},{"key":"BFni3684_CR22","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1172\/JCI84428","volume":"126","author":"DJ DiLillo","year":"2016","unstructured":"DiLillo, D.J., Palese, P., Wilson, P.C. & Ravetch, J.V. Broadly neutralizing anti-influenza antibodies require Fc receptor engagement for in vivo protection. J. Clin. Invest. 126, 605\u2013610 (2016).","journal-title":"J. Clin. Invest."},{"key":"BFni3684_CR23","doi-asserted-by":"publisher","first-page":"13463","DOI":"10.1128\/JVI.05193-11","volume":"85","author":"M Terajima","year":"2011","unstructured":"Terajima, M. et al. Complement-dependent lysis of influenza a virus-infected cells by broadly cross-reactive human monoclonal antibodies. J. Virol. 85, 13463\u201313467 (2011).","journal-title":"J. Virol."},{"key":"BFni3684_CR24","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/nm.3443","volume":"20","author":"DJ DiLillo","year":"2014","unstructured":"DiLillo, D.J., Tan, G.S., Palese, P. & Ravetch, J.V. Broadly neutralizing hemagglutinin stalk-specific antibodies require Fc\u03b3R interactions for protection against influenza virus in vivo. Nat. Med. 20, 143\u2013151 (2014).","journal-title":"Nat. Med."},{"key":"BFni3684_CR25","doi-asserted-by":"publisher","first-page":"13260","DOI":"10.1128\/JVI.02133-14","volume":"88","author":"R Nachbagauer","year":"2014","unstructured":"Nachbagauer, R. et al. Induction of broadly reactive anti-hemagglutinin stalk antibodies by an H5N1 vaccine in humans. J. Virol. 88, 13260\u201313268 (2014).","journal-title":"J. Virol."},{"key":"BFni3684_CR26","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/j.chom.2016.05.014","volume":"19","author":"CJ Henry Dunand","year":"2016","unstructured":"Henry Dunand, C.J. et al. Both neutralizing and non-neutralizing human H7N9 influenza vaccine-induced monoclonal antibodies confer protection. Cell Host Microbe 19, 800\u2013813 (2016).","journal-title":"Cell Host Microbe"},{"key":"BFni3684_CR27","doi-asserted-by":"publisher","first-page":"6334","DOI":"10.1128\/JVI.07158-11","volume":"86","author":"JC Krause","year":"2012","unstructured":"Krause, J.C. et al. Human monoclonal antibodies to pandemic 1957 H2N2 and pandemic 1968 H3N2 influenza viruses. J. Virol. 86, 6334\u20136340 (2012).","journal-title":"J. Virol."},{"key":"BFni3684_CR28","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1038\/nature08182","volume":"459","author":"GJ Smith","year":"2009","unstructured":"Smith, G.J. et al. Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic. Nature 459, 1122\u20131125 (2009).","journal-title":"Nature"},{"key":"BFni3684_CR29","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/ni.2761","volume":"15","author":"F Krammer","year":"2014","unstructured":"Krammer, F. & Palese, P. Universal influenza virus vaccines: need for clinical trials. Nat. Immunol. 15, 3\u20135 (2014).","journal-title":"Nat. Immunol."},{"key":"BFni3684_CR30","doi-asserted-by":"publisher","first-page":"198ra107","DOI":"10.1126\/scitranslmed.3006637","volume":"5","author":"MS Miller","year":"2013","unstructured":"Miller, M.S. et al. Neutralizing antibodies against previously encountered influenza virus strains increase over time: a longitudinal analysis. Sci. Transl. Med. 5, 198ra107 (2013).","journal-title":"Sci. Transl. Med."},{"key":"BFni3684_CR31","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.coviro.2013.07.007","volume":"3","author":"F Krammer","year":"2013","unstructured":"Krammer, F. & Palese, P. Influenza virus hemagglutinin stalk-based antibodies and vaccines. Curr. Opin. Virol. 3, 521\u2013530 (2013).","journal-title":"Curr. Opin. Virol."},{"key":"BFni3684_CR32","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1084\/jem.20130212","volume":"210","author":"Y Li","year":"2013","unstructured":"Li, Y. et al. Immune history shapes specificity of pandemic H1N1 influenza antibody responses. J. Exp. Med. 210, 1493\u20131500 (2013).","journal-title":"J. Exp. Med."},{"key":"BFni3684_CR33","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1126\/science.1176225","volume":"325","author":"RJ Garten","year":"2009","unstructured":"Garten, R.J. et al. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 325, 197\u2013201 (2009).","journal-title":"Science"},{"key":"BFni3684_CR34","doi-asserted-by":"publisher","first-page":"9047","DOI":"10.1073\/pnas.1118979109","volume":"109","author":"GM Li","year":"2012","unstructured":"Li, G.M. et al. Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells. Proc. Natl. Acad. Sci. USA 109, 9047\u20139052 (2012).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFni3684_CR35","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1056\/NEJMoa1304459","volume":"368","author":"R Gao","year":"2013","unstructured":"Gao, R. et al. Human infection with a novel avian-origin influenza A (H7N9) virus. N. Engl. J. Med. 368, 1888\u20131897 (2013).","journal-title":"N. Engl. J. Med."},{"key":"BFni3684_CR36","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/S0140-6736(14)60111-2","volume":"383","author":"H Chen","year":"2014","unstructured":"Chen, H. et al. Clinical and epidemiological characteristics of a fatal case of avian influenza A H10N8 virus infection: a descriptive study. Lancet 383, 714\u2013721 (2014).","journal-title":"Lancet"},{"key":"BFni3684_CR37","doi-asserted-by":"crossref","unstructured":"Mart\u00ednez-Sobrido, L. & Garc\u00eda-Sastre, A. Generation of recombinant influenza virus from plasmid DNA. J. Vis. Exp. 42, 2057 (2010).","DOI":"10.3791\/2057"},{"key":"BFni3684_CR38","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1007\/s12033-010-9268-3","volume":"45","author":"F Krammer","year":"2010","unstructured":"Krammer, F. et al. Trichoplusia ni cells (High Five) are highly efficient for the production of influenza A virus-like particles: a comparison of two insect cell lines as production platforms for influenza vaccines. Mol. Biotechnol. 45, 226\u2013234 (2010).","journal-title":"Mol. Biotechnol."},{"key":"BFni3684_CR39","doi-asserted-by":"publisher","first-page":"e43603","DOI":"10.1371\/journal.pone.0043603","volume":"7","author":"F Krammer","year":"2012","unstructured":"Krammer, F. et al. A carboxy-terminal trimerization domain stabilizes conformational epitopes on the stalk domain of soluble recombinant hemagglutinin substrates. PLoS One 7, e43603 (2012).","journal-title":"PLoS One"},{"key":"BFni3684_CR40","first-page":"e51112","volume":"81","author":"I Margine","year":"2013","unstructured":"Margine, I., Palese, P. & Krammer, F. Expression of functional recombinant hemagglutinin and neuraminidase proteins from the novel H7N9 influenza virus using the baculovirus expression system. J. Vis. Exp. 81, e51112 (2013).","journal-title":"J. Vis. Exp."},{"key":"BFni3684_CR41","doi-asserted-by":"publisher","first-page":"10493","DOI":"10.1128\/JVI.00959-08","volume":"82","author":"X Xu","year":"2008","unstructured":"Xu, X., Zhu, X., Dwek, R.A., Stevens, J. & Wilson, I.A. Structural characterization of the 1918 influenza virus H1N1 neuraminidase. J. Virol. 82, 10493\u201310501 (2008).","journal-title":"J. Virol."},{"key":"BFni3684_CR42","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1126\/science.1093373","volume":"303","author":"J Stevens","year":"2004","unstructured":"Stevens, J. et al. Structure of the uncleaved human H1 hemagglutinin from the extinct 1918 influenza virus. Science 303, 1866\u20131870 (2004).","journal-title":"Science"},{"key":"BFni3684_CR43","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1126\/science.1256427","volume":"346","author":"JM Fonville","year":"2014","unstructured":"Fonville, J.M. et al. Antibody landscapes after influenza virus infection or vaccination. Science 346, 996\u20131000. (2014).","journal-title":"Science"},{"key":"BFni3684_CR44","doi-asserted-by":"publisher","first-page":"e25953","DOI":"10.1371\/journal.pone.0025953","volume":"6","author":"K Ito","year":"2011","unstructured":"Ito, K. et al. Gnarled-trunk evolutionary model of influenza A virus hemagglutinin. PLoS One 6, e25953 (2011).","journal-title":"PLoS One"},{"key":"BFni3684_CR45","unstructured":"Borg, I. & Groenen, P. Modern Multidimensional Scaling: Theory and Applications (Springer, 2005)."}],"container-title":["Nature Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/ni.3684.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ni.3684","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ni.3684.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T22:43:53Z","timestamp":1733957033000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ni.3684"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,13]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["BFni3684"],"URL":"https:\/\/doi.org\/10.1038\/ni.3684","relation":{},"ISSN":["1529-2908","1529-2916"],"issn-type":[{"value":"1529-2908","type":"print"},{"value":"1529-2916","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,13]]},"assertion":[{"value":"19 September 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}